Tuan Nguyen
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Tuan Nguyen is currently Chief Financial Officer at Arbutus Biopharma Corp.
since 2025.
Formerly, Mr. Nguyen was Chief Financial Officer at Kinevant Sciences, Inc. from 2022 to 2025 and Vice President-Finance at Adverum Biotechnologies, Inc. from 2020 to 2022.
Education includes an undergraduate degree from Louisiana Tech University and an MBA from Emory University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Directeur Financier/CFO | 28/03/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Kinevant Sciences, Inc.
Kinevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases | Directeur Financier/CFO | 01/03/2025 |
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur Financier/CFO | 01/03/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Louisiana Tech University
Louisiana Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Kinevant Sciences, Inc.
Kinevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national